Project Grant R01MH140440
Award Date
7/7/25
Completion Date
5/31/30
Dollars Obligated
$1.2M
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Institute of Mental Health
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Illinois, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $702,000 to support a 3-year project aimed at optimizing the implementation of long-acting injectable pre-exposure prophylaxis (LAI-PrEP) for HIV prevention. The key objectives are to: 1) Identify barriers and facilitators to LAI-PrEP implementation, 2) Determine optimal implementation strategies in partnership with...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $381,487 to the University of Maryland, Baltimore (UMB) to assess the early implementation of long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) at high risk of HIV acquisition in Zambia. The key objectives are to: 1) Evaluate implementation determinants of CAB-LA...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,681,276 to the Research Foundation of the City University of New York (RFCUNY) to conduct research on optimizing long-acting injectable (LAI) pre-exposure prophylaxis (PrEP) strategies for sexual minority men (SMM) who use methamphetamine. The study aims to qualitatively identify modifiable care options for LAI PrEP use through rapid interviews,...
The federal Project Grant award, R61AI188553, was provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award totaling $2,207,322 aims to develop ultra-long-acting antiretroviral therapy (ART) formulations for the treatment of HIV-1 infection in pediatric populations. The approach involves transforming established daily oral pediatric ART regimens,...
This Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to assess the availability and implementation of integrated HIV and overdose prevention services in pharmacies across Illinois and North Carolina. The total funding amount is $762,479, with an award date of July 1, 2025 and an ultimate completion date of March 31, 2030. The key objectives of this project are to: 1) evaluate changes in the...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to adapt and evaluate the effectiveness of the Comprehensive Adherence Resource and Empowerment Support (CARES) intervention to increase pre-exposure prophylaxis (PrEP) continuation and adherence among adolescent girls and young women in South Africa and Zimbabwe. The total funding amount is $710,187, with an award date of September 11, 2024 and an...
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to implement an innovative HIV self-testing and long-acting injectable HIV treatment and prevention intervention for commercial minibus drivers in Nigeria. The $809,692 award to The George Washington University, with sub-awards to Wake Forest University Health Sciences, University of Rochester, Emory...
This $452,376 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to develop a predictive model for identifying HIV patients at risk of disengaging from medical care. The University of Chicago is conducting this 2-year project, which has two key objectives: Determine the performance of a Natural Language Processing (NLP) model for predicting loss to follow-up (LTFU) from HIV care across...
This $221,635 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support a community-engaged modeling and implementation science project to develop re-linkage interventions for Black sexual minority men with HIV. The project aims to use agent-based modeling, qualitative data, and implementation science methods to characterize barriers to HIV care engagement and identify strategies to improve re-linkage,...
This $677,589 Project Grant award from the National Institutes of Health (NIH) Office of the Director's Trans-NIH Research Support program (CFDA 93.310) supports the development and pilot testing of a novel HIV prevention program targeting women experiencing incarceration. The "FIT for PrEP" (F4P) program aims to link these high-risk women to post-release pre-exposure prophylaxis (PrEP) services and address associated social determinants of health during community re-entry. Key aspects...